Mitogenic properties of a bispecific single-chain Fv-Ig fusion generated from CD2-specific mAb to distinct epitopes

International Immunology

Volumn 10, Issue 12, 1998, Pages 1863-1872

  Connelly, Roberta J ^a   Hayden, Martha S ^a,c   Scholler, John K ^a,d   Tsu, Theta T ^a,c   Dupont, Bo ^b   Ledbetter, Jeffrey A ^a,c   Kanner, Steven B ^a  

^a BRISTOL MYERS SQUIBB   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c Xcyte Therapies   (United States)

^d GLAXOSMITHKLINE   (United States)

Author keywords

Antibodies; Cellular activation; Co stimulatory molecules; Signaling; T lymphocytes

Indexed keywords

CALCIUM ION; CD2 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; MONOCLONAL ANTIBODY;

ACCESSORY CELL; ARTICLE; BINDING SITE; CALCIUM MOBILIZATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOGLOBULIN VARIABLE REGION; LYMPHOCYTE PROLIFERATION; MITOGENESIS; MIXED LYMPHOCYTE REACTION; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN DOMAIN; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0031672581     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/10.12.1863     Document Type: Article

References (66)

1. Bierer, B. E. and Hahn, W. C. 1993. T cell adhesion, avidity regulation and signaling: a molecular analysis of CD2. Semin. Immunol. 5:249.
2. Davis, S. J. and van der Merwe, P. A. 1996. The structure and ligand interactions of CD2: implications for T cell function. Immunol. Today 17:177.
3. Collins, T. L., Hahn, W. C., Bierer, B. E. and Burakoff, S. J. 1993. CD4, CD8 and CD2 in T cell adhesion and signaling. Curr. Top. Microbiol. Immunol. 184:223.
4. Hahn, W. C., Menu, E., Bothwell, A. L., Sims, P. J. and Bierer, B. E. 1992. Overlapping but nonidentical binding sites on CD2 for CD58 and a second ligand CD59. Science 256:1805.
5. Deckert, M., Kubar, J., Zoccola, D., Bernard-Pomier, G., Angelisova, P., Horejsi, V. and Bernard, A. 1992. CD59molecule: a second ligand for CD2 in T cell adhesion. Eur. J. Immunol. 22:2943.
6. Meuer, S. C., Hussey, R. E., Fabbi, M., Fox, D., Acuto, O., Fitzgerald, K. A., Hodgdon, J. C., Protentis, J. P., Schlossman, S. and Reinherz, E. L. 1988. An alternative pathway of T cell activation: a functional role of the 50 kd sheep erylhrocyte receptor protein. Cell 36:897.
7. Hunig, T., Tiefenthaler, G., Meyer zum Buschenfelde, K. H. and Meuer, S. C. 1987. Alternative pathway activation of T cells by binding of CD2 to its cell-surface ligand. Nature 326:298.
8. Howard, F. D., Moingeon, P., Moebius, U., McConkey, D. J., Yandava, B., Gennert, T. E. and Reinherz, E. L. 1992. The CD3ζ cytoplasmic domain mediates CD2-induced T cell activation. J. Exp. Med. 176:139.
9. Koretzky, G. A., Picus, J., Schultz, T. and Weiss, A. 1991. Tyrosine phosphatase CD45 is required for T cell antigen receptor and CD2-mediated activation of a protein tyrosine kinase and interleukin 2 production. Proc. Natl Acad. Sci. USA 88:2037.
10. Schraven, B., Samstag, Y., Altevogt, P. and Meuer, S. C. 1990. Association of CD2 and CD45 on human T lymphocytes. Nature 345:71.
11. Samelson, L. E., Fletcher, J. A., Ledbetter, J. A. and June, C. A. 1990. Activation of tyrosine phosphorylation in human T cells via the CD2 pathway. Regulation by the CD45 tyrosine phosphatase. J. Immunol. 145:2448.
12. Altevogt, P., Schreck, J., Schraven, B., Meuer, S., Schirrmacher, V. and Mitsch, A. 1990. Association of CD2 and T200 (CD45) in mouse T lymphocytes. Int. Immunol. 2:353.
13. Brown, M. H., Cantrell, D. A., Brattsand, G., Crumpton, M. J. and Gullberg, M. 1989. The CD2 antigen associates with the T cell antigen receptor CD3 antigen complex on the surface of human T lymphocytes. Nature 339:551.
14. Vivier, E., Morin, P. M., O'Brien, C., Schlossman, S. F. and Anderson, P. 1991. CD2 is functionally linked to ζ-natural killer receptor complex. Eur J. Immunol. 21:1077.
15. Spruyt, L. L., Glennie, M. J., Beyers, A. D. and Williams, A. F. 1991. Signal transduction by the CD2 antigen in T cells and natural killer cells: requirement for expression of a functional T cell receptor or binding of antibody Fc to the Fc receptor, FcγRIIIA (CD16). J. Exp. Med. 174:1407.
16. + cells. J. Exp. Med. 173:859.
17. lck binds to proline-rich sequences in the cytoplasmic domain of CD2 J. Exp. Med. 183:169.
18. fyn. Eur. J. Immunol. 23:2196.
19. Bell, G. M., Bolen, J. B. and Imboden, J. B. 1992. Association of Src-like protein tyrosine kinases with the CD2 cell surface molecule in rat T lymphocytes and natural killer cells. Mol. Cell. Biol. 12:5548.
20. lck. Eur. J. Immunol. 22:2915.
21. fyn in T lymphocytes. Eur. J. Immunol 24:139.
22. King, P. D., Sandra, A., Han, A., Liu, X-R., Sunder-Plassmann, R., Reinherz, E. L. and Dupont, B. 1996. CD2 signaling in T cells involves tyrosine phosphorylation and activation of the Tec family kinase, EMT/ITK/TSK. Int. Immunol. 8:1707.
23. Tanaka, N., Abe, H., Yagita, H., Okumura, K., Nakamura, M. and Sugamura, K. 1997. Itk, a T cell-specific tyrosine kinase, is required for CD2-mediated interleukin-2 promoter activation in the human T cell line Jurkat. Eur. J. Immunol. 27:834.
24. Kanner, S. B., Damle, N. K., Blake, J., Aruffo, A. and Ledbetter, J. A. 1992. CD2/LFA-3 ligation induces phospholipase-Cγ1 tyrosine phosphorylation and regulates CD3 signaling. J. Immunol. 148.2023.
25. Ley, S. C., Davies, A. A., Druker, B. and Crumpton, M. J. 1991. The T cell receptor/CD3 complex and CD2 stimulate the tyrosine phosphorylation of indistinguishable patterns of polypeptides in the human T leukemic cell line Jurkat. Eur. J. Immunol. 21:2203.
26. Casnellie, J. E. and Thom, R. E. 1990. An activating combination of CD2 antibodies stimulates tyrosine phosphorylation in a T lymphocyte cell line. FEBS Lett. 261:331.
27. Monostori, E., Desai, D., Brown, M. H., Cantrell, D. A. and Crumpton, M. J. 1990. Activation of human T lymphocytes via the CD2 antigen results in tyrosine phosphorylation of T cell antigen receptor ζ-chains. J. Immunol. 144:1010.
28. Ledbetter, J. A., Rabinovitch, P. S., Hellstrom, I., Hellstrom, K. E., Grosmaire, L. S. and June, C. H. 1988. Role of CD2 cross-linking in cytoplasmic calcium responses and T cell activation. Eur. J. Immunol. 18:1601.
29. Ohno, H., Ushiyama, C., Taniguchi, M., Germain, R. N. and Saito, T. 1991. CD2 can mediate TCR/CD3-independent T cell activation. J. Immunol. 146:3742.
30. 2+ independently. Eur. J. Immunol. 16:580.
31. Cerdan, C., Lipcey, C., Lopez, M., Nunes, J., Pierres, A., Mawas, C. and Olive, D. 1989. Monoclonal antibodies against LFA-1 or its ligand ICAM-1 accelerate CD2 (T11.1 + T11.2)-mediated T cell proliferation. Cell. Immunol. 123:344.
32. Pierres, A., Lopez, M., Cerdan, C., Nunes, J., Olive, D. and Mawas, C. 1988. Triggering CD28 molecules synergize with CD2 (T11.1 and T11.2)-mediated T cell activation. Eur. J. Immunol. 18:685.
33. Martin, P. J., Longton, G., Ledbetter, J. A., Newman, W., Braun, M. P., Beatty, P. G. and Hansen, J. A. 1983. Identification and functional characterization of two distinct epitopes on the human T cell surface protein Tp50. J. Immunol. 131:180.
34. Yang, S. Y., Chouaib, S. and Dupont, B. 1986. A common pathway for T lymphocyte activation involving both the CD3-Ti complex and CD2 sheep erythrocyte receptor determinants. J. Immunol. 137:1097.
35. Horibe, K. and Nadler, L. M. 1984. Human B cell associated antigens defined by monoclonal antibodies. In Heise, E. L., ed., Lymphocyte Surface Antigens, p. 309. American Society for Histocompatability and Immunogenetics, New York.
36. Anasetti, C., Martin, P. J., June, C. H., Hellstrom, K. E., Ledbetter, J. A., Rabinovitch, P. S., Morishita, Y., Hellstrom, I. and Hansen, J. A. 1987. Induction of calcium flux and enhancement of cytolytic activity in natural killer cells by cross-linking of the sheep erythrocyte binding protein (CD2) and the Fc-receptor (CD16). J. Immunol. 139:1772.
37. Hansen, J. A., Martin, P. J., Beatty, P. G., Clark, E. A. and Ledbetter, J. A. 1984. Human T lymphocyte surface antigens defined by the workshop monoclonal antibodies. In Bernard, A., Boumsell, L., Bausset, J., Milstein, C. and Sclossman, S. F., eds, Leukocyte Typing, p. 195, Springer-Verlag, New York.
38. Ledbetter, J. A., Tsu, T. T. and Clark, E. A. 1985. Covalent association between human thymus-leukemia like antigens and CD8(Tp32). J. Immunol. 134:4250.
39. Ledbetter, J. A. and Clark, E. A. 1986. Surface phenotype and function of tonsillar germinal center and mantle zone B cell subsets. Hum. Immunol. 15:30.
40. Linsley, P. S., Brady, W., Urnes, M., Grosmaire, L. S., Damle, N. K. and Ledbetter, J. A. 1991. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174:561.
41. Hayden, M. S., Gilliland, L. K. and Ledbetter, J. A. 1997. Antibody engineering. Curr. Opin. Immunol. 9:201.
42. Hayden, M. S., Linsley, P. S., Gayle, M. A., Bajorath, J., Brady, W. A., Norris, N. A., Fell, H. P., Ledbetter, J. A. and Gilliland, L. K. 1994. Single-chain mono- and bispecific antibody derivatives with novel biological properties and antitumor activity from a COS cell transient expression system. Ther. Immunol. 1:3.
43. Gilliland, L. K., Norris, N. A., Marquardt, H., Tsu, T. T., Hayden, M. S., Neubauer, M. G., Yelton, D. E., Mittler, R. S. and Ledbetter, J. A. 1996. Rapid and reliable cloning of antibody variable regions and generation of recombinant single chain antibody fragments. Tissue Antigens 47:1.
44. Diegel, M. L., Moran, P. A., Gilliland, L K., Damle, N. K., Hayden, M. S., Zarling, J. M. and Ledbetter, J. A. 1993. Regulation of HIV production by blood mononuclear cells from HIV-infected donors: II. HIV-1 production depends on T cell-monocyte interaction. AIDS Res. Hum. Retroviruses 9:465.
45. Zarling, J. M., Moran, P. A., Burke, R. L., Pachl, C., Berman, P. W. and Lasky, L. A. 1986. Human cytotoxic T cell clones directed against herpes simplex virus infected cells: IV. Recognition and activation by cloned glycoproteins gB and gD. J. Immunol. 136:4669.
46. Warren, H. S., McPhun, V., Bezos, A. and Parish, C. R. 1988. The T11(3) epitope of the CD2 molecule, sheep erythrocytes, and the alternative T cell activation pathway. Immunology 63:345.
47. Van Lier, R. A. W., Brouwer, M. and Aarden, L. A. 1988. Signals involved in T cell activation. T cell proliferation induced through the synergistic action of anti-CD28 and anti-CD2 monoclonal antibodies. Eur. J. Immunol. 18:167.
48. Bell, G. M. and Imboden, J. B. 1995. CD2 and the regulation of T cell anergy. J. Immunol. 155:2805.
49. Schad, V., Greenstein, J. L., Giovino-Barry, V., LeGuern, A., Matejic, T., Glaser, R., Dickerson, M., Xu, Y., Bazin, H., Latinne, D., Monroy, R, and White-Scharf, M. E. 1996. An anti-CD2 monoclonal antibody that elicits alloantigen-specific hyporesponsiveness. Transplant. Proc. 28:2051.
50. Chavin, K. D., Lau, H. T. and Bromberg, J. S. 1992. Prolongation of allograft and xenograft survival in mice by anti-CD2 monoclonal antibodies Transplantation 54:286.
51. Guckel, B., Berek, C., Lutz, M., Altevogt, P., Schirrmacher, V. and Kyewski, B. A. 1991. Anti-CD2 antibodies induce T cell unresponsiveness in vivo. J. Exp. Med. 174:957.
52. Jung, S., Toyka, K. and Hartung, H-P. 1995. Suppression of experimental autoimmune encephalomyelitis in Lewis rats by antibodies to CD2. Eur. J. Immunol. 25:1391.
53. Hirahara, H., Tsuchida, M., Watanabe, T., Haga, M., Matsumoto, Y., Abo, T. and Eguchi, S. 1995. Long-term survival of cardiac allografts in rats treated before and after surgery with monoclonal antibody to CD2. Transplantation 59:85.
54. Qin, L., Chavin, K. D., Lin, J., Yagita, H. and Bromberg, J. S. 1994. Anti-CD2 receptor and anti-CD2 ligand (CD48) antibodies synergize to prolong allograft survival. J. Exp. Med. 179:341.
55. Tan, P., Anasetti, C., Hansen, J. A., Melrose, J., Brunvand, M., Bradshaw, J., Ledbetter, J. A. and Linsley, P. S. 1993. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. J. Exp. Med. 177:165.
56. Kato, K., Koyanagi, M., Okada, H., Takanashi, T., Wong, Y. W., Williams, A. F., Okumura, K. and Yagita, H. 1992. CD48 is a counter-receptor for mouse CD2 and is involved in T cell activation. J. Exp. Med. 176:1241.
57. Killeen, N., Stuart, S. G. and Littman, D. R 1992. Development and function of T cells in mice with a disrupted CD2 gene. EMBO J. 11:4329.
58. Evans, C. F., Rail, G. F., Killeen, N., Littman, D. and Oldstone. M. B. A. 1993. CD2-deficient mice generate virus-specific cytotoxic T lymphocytes upon infection with lymphocytic choriomeningitis virus. J. Immunol. 151:6259.
59. Sandrin, M. S., Mouhtouris, E., Vaughan, H. A., Warren, H. S. and Parish, C. R. 1993. CD48 is a low affinity ligand for human CD2. J. Immunol. 151:4606.
60. Arulanandam, A. R. N., Moingeon, P., Concino, M. F., Recny, M. A., Kato, K., Yagita, H., Koyasu, S. and Reinherz, E. L. 1993. A soluble multimeric recombinant CD2 protein identifies CD48 as a low affinity ligand for human CD2: divergence of CD2 ligands during the evolution of humans and mice. J. Exp. Med. 177:1439.
61. Linsley, P. S. and Ledbetter, J. A. 1993. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11:191.
62. Lenschow, D. J., Walunas, T. L. and Bluestone, J. A. 1996. CD28/B7 system of T cell co-stimulation. Annu. Rev. Immunol. 14:233.
63. Boussiotis, V. A., Freeman, G. J., Gribben, J. G. and Nadler, L. M. 1996. The role of B7-1/B7-2:CD28/CTLA-4 pathways in the prevention of anergy, induction of productive immunity and down-regulation of the immune response. Immunol. Rev. 153:5.
64. Chavin, K. D., Qin, L., Lin, J., Kaplan, A. J. and Bromberg, J. S. 1993. Anti-CD2 and anti-CD3 monoclonal antibodies synergize to prolong allograft survival with decreased side effects. Transplantation 55:901.
65. Chavin, K. D., Qin, L., Lin, J., Yagita, H. and Bromberg, J. S. 1993. Combined anti-CD2 and anti-CD3 receptor monoclonal antibodies induce donor-specific tolerance in a cardiac transplant model. J. Immunol. 151:7249.
66. Cavazzana-Calvo, M., Jabado, N., Bordigoni, P., Michel, G., Haddad, E., Mechinaud, F., Landman-Parker, J., Leblanc, T., Plouvier, E., Baruchel, A., Stephan, J. L., Souillet, G., Vilmer, E., Wijdenes, J., Le Deist, F. and Fischer, A. 1997. In vivo infusion of anti-LFA-1 and anti-CD2 antibodies prevents graft failure after HLA partially incompatible bone marrow transplantation in children with high risk acute lymphoblastic leukemia. Leuk. Lymphoma 28:103.